BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34603481)

  • 1. Correlation between
    Hu S; Zhao X; Qian F; Jin C; Hou K
    Comput Math Methods Med; 2021; 2021():1522250. PubMed ID: 34603481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma.
    Yu G; Mu H; Fang F; Zhou H; Li H; Wu Q; Xiong Q; Cui Y
    Medicine (Baltimore); 2022 Jul; 101(26):e29763. PubMed ID: 35777027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown LC; Tucker MD; Sedhom R; Schwartz EB; Zhu J; Kao C; Labriola MK; Gupta RT; Marin D; Wu Y; Gupta S; Zhang T; Harrison MR; George DJ; Alva A; Antonarakis ES; Armstrong AJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
    Han R; Chen G; Li M; Peng ZM; Xu L
    Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer.
    Lu YJ; Wu CS; Li HP; Liu HP; Lu CY; Leu YW; Wang CS; Chen LC; Lin KH; Chang YS
    Genes Chromosomes Cancer; 2010 May; 49(5):412-24. PubMed ID: 20095042
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Huang T; Liang Y; Zhang H; Chen X; Wei H; Sun W; Wang Y
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma.
    Liu F; Hou W; Liang J; Zhu L; Luo C
    J Cancer; 2021; 12(13):4039-4048. PubMed ID: 34093808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
    Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T
    J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.
    Xu J; Shen X; Zhang B; Su R; Cui M; Yan L; Cao Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34386813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
    Yu Y; Xie Z; Zhao M; Lian X
    BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of
    Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.
    Zhu M; Zhang L; Cui H; Zhao Q; Wang H; Zhai B; Jiang R; Jiang Z
    Front Immunol; 2021; 12():800951. PubMed ID: 35069585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
    Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
    Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
    Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
    FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
    Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
    Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
    Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment.
    Cheng Y; Tang R; Li X; Wang B; Cheng Y; Xiao S; Sun P; Yu W; Li C; Lin X; Zhu Y
    J Hepatocell Carcinoma; 2022; 9():203-220. PubMed ID: 35345553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.